IQVIA Holdings (NYSE: IQV) officer sells 1,855 common shares at $235.27

Rhea-AI Filing Summary

IQVIA Holdings Inc. officer Patel Bhavik, President, MedTech and Consumer Health, reported selling 1,855 shares of common stock on July 31, 2026. The sale was at a weighted average price of $235.27 per share, with individual trades between $235.22 and $235.29. Following this transaction, Bhavik directly holds 1,348 shares of IQVIA common stock.

Insider Trade Summary

Net Seller: 1,855 shares

Net Sell 1 txn

Insider Patel Bhavik

Role See Remarks

Sold 1,855 shs ($436K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	1,855	$235.27	$436K

Holdings After Transaction: Common Stock — 1,348 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.22 to $235.29, inclusive.

Key Figures

Shares Sold: 1,855 shares Weighted Average Sale Price: $235.27 per share Sale Price Range: $235.22–$235.29 per share +2 more

5 metrics

Shares Sold 1,855 shares Common stock sold by officer on July 31, 2026

Weighted Average Sale Price $235.27 per share Average price across multiple sale transactions

Sale Price Range $235.22–$235.29 per share Price range of individual trades in the reported sale

Shares Owned After Transaction 1,348 shares Direct holdings after the July 31, 2026 sale

Transaction Date July 31, 2026 Date of reported common stock sale

Key Terms

weighted average price, Common Stock, open market or private transaction, power of attorney

4 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open market or private transaction financial

"transaction_code_description: "Sale in open market or private transaction""

power of attorney regulatory

"President, MedTech and Consumer Health Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/04/2026 - 05:00 PM Accepted by SEC EDGAR 08/04/2026 - 05:00 PM Learn about SEC filing dates

FAQ

What insider transaction did Patel Bhavik report for IQV on this Form 4?

Patel Bhavik reported a sale of 1,855 shares of IQVIA Holdings Inc. common stock. The transaction occurred on July 31, 2026, and left him with 1,348 shares held directly after the sale.

At what price did Patel Bhavik sell IQVIA (IQV) common stock?

The shares were sold at a weighted average price of $235.27 per share. According to the filing, individual trade prices during the sale ranged from $235.22 to $235.29, inclusive, across multiple transactions.

How many IQVIA (IQV) shares does Patel Bhavik own after this reported sale?

After the reported sale, Patel Bhavik directly owns 1,348 shares of IQVIA common stock. This figure reflects his post-transaction holdings as disclosed in the Form 4 following the July 31, 2026 sale.

When did the reported IQVIA (IQV) insider transaction by Patel Bhavik take place?

The reported insider transaction took place on July 31, 2026. On that date, Patel Bhavik sold 1,855 shares of IQVIA common stock at a weighted average price of $235.27 per share across multiple trades.

What role does Patel Bhavik hold at IQVIA Holdings (IQV) according to the Form 4?

Patel Bhavik is identified as an officer of IQVIA Holdings Inc., serving as President, MedTech and Consumer Health. This officer role is noted in the remarks section accompanying the reported stock sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Patel Bhavik

(Last) (First) (Middle)

C/O IQVIA HOLDINGS INC.

2400 ELLIS ROAD

(Street)

DURHAM NORTH CAROLINA 27703

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/31/2026		S		1,855	D	$235.27(1)	1,348	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.22 to $235.29, inclusive.

Remarks:

President, MedTech and Consumer Health Power of Attorney

	/s/ Abigail Jeck, Attorney-in-Fact for Bhavik Patel	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)